Genentech Biotechnology Manufacturing Plant
Sector: Residential • Location: Holly Springs, North Carolina, United States
Source: Spectrum News
Genentech plans to establish a new $700 million drug manufacturing plant in Holly Springs, North Carolina, which is expected to create 400 jobs and significantly boost the local economy.
- Status
- Prospective
- Sector
- Residential, Commercial, Manufacturing (Industrial)
- Location
- Holly Springs, North Carolina, United States of America
- Updated
- 22 Jul 2026
- Source
- Spectrum News
ConstructChat
Ask ConstructChat about Genentech Biotechnology Manufacturing Plant
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Genentech plans to establish a new $700 million drug manufacturing plant in Holly Springs, North Carolina, which is expected to create 400 jobs and significantly boost the local economy. |
Budget |
Location
Country | United States of America (USA) |
State | North Carolina |
City | Holly Springs |
Source
Source | Spectrum News |
URL |
More Details
Record type | Project |
Sector | Residential, Commercial, Manufacturing (Industrial) |
Article published date | 2025-05-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Residential projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Tampa Bay Seawater Desalination Plant
- Portugues Dam, Ponce
- Sinking Creek Wastewater Treatment Plant Expansion, Tennessee
- Carlsbad Desalination Project, San Diego, California
- Fort Riley Army Base, Kansas
- Fort Benning, Georgia
- Fort Dix, US Army Base, New Jersey
